![Stefan Glombitza](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Stefan Glombitza is currently the Chief Executive Officer at Formycon AG since 2022.
Previously, he worked at Hexal AG as a Manager-Medical Affairs and at Hexal Pharmaforschung GmbH as the Head-Project Management.
Dr. Glombitza holds a doctorate degree from the University of Regensburg.
Postes actifs de Stefan Glombitza
| Sociétés | Poste | Début |
|---|---|---|
| FORMYCON AG | Directeur Général | 01/07/2022 |
Anciens postes connus de Stefan Glombitza
| Sociétés | Poste | Fin |
|---|---|---|
Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Corporate Officer/Principal | - |
Formation de Stefan Glombitza
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells pharmaceutical products | Health Technology |
University of Regensburg
 University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Formycon AG
 Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Hexal Pharmaforschung GmbH |
